Meeting Coverage

TCTM

Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR

Allo-Transplant With Omidubicel Hints at Longer-Term Benefits Too

"Viable" option for patients eligible for umbilical cord blood transplantation, investigator says

TCTM over a photo of Salt Palace Convention Center, Salt Lake City, UT

Latest TCTM Meetings

Promising Data for Allo-Transplant After CAR T-Cell Failure in LBCL

Durable responses with no unexpected or prolonged safety issues

April 27, 2022
Eprenetapopt-Based Combo Impresses in TP53-Mutant AML/MDS

1-year relapse-free survival rate of 60% with maintenance therapy after transplant

April 25, 2022